Matthew Hill Net Worth

The estimated Net Worth of Matthew C Hill is at least $25 mil dollars as of 13 August 2024. Mr. Hill owns over 5,336 units of STRATA Skin Sciences Inc stock worth over $25,036 and over the last 7 years he sold SSKN stock worth over $0. In addition, he makes $0 as Chief Financial Officer at STRATA Skin Sciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Hill SSKN stock SEC Form 4 insiders trading

Matthew has made over 4 trades of the STRATA Skin Sciences Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 5,336 units of SSKN stock worth $6,030 on 13 August 2024.

The largest trade he's ever made was buying 10,000 units of STRATA Skin Sciences Inc stock on 14 June 2018 worth over $19,600. On average, Matthew trades about 2,094 units every 225 days since 2018. As of 13 August 2024 he still owns at least 7,836 units of STRATA Skin Sciences Inc stock.

You can see the complete history of Mr. Hill stock trades at the bottom of the page.

Matthew Hill biography

Matthew C. Hill is Chief Financial Officer of the company. He was the Chief Financial Officer of SS White Burs, Inc., a privately held medical device manufacturer, where he had worked from 2010. In addition to his experience at SS White Burs, Inc. Mr. Hill has over 20 years of experience in various capacities in public and private companies, and in public accounting with Grant Thornton LLP. Mr. Hill graduated with a B.S. in accounting from Lehigh University in 1991.

How old is Matthew Hill?

Matthew Hill is 44, he's been the Chief Financial Officer of STRATA Skin Sciences Inc since 2018. There are 11 older and no younger executives at STRATA Skin Sciences Inc. The oldest executive at STRATA Skin Sciences Inc is Dr. Darrell S. Rigel, 70, who is the Chief Medical Advisor.

What's Matthew Hill's mailing address?

Matthew's mailing address filed with the SEC is C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER, FL, 33760.

Insiders trading at STRATA Skin Sciences Inc

Over the last 9 years, insiders at STRATA Skin Sciences Inc have traded over $348,780 worth of STRATA Skin Sciences Inc stock and bought 2,664,087 units worth $2,970,754 . The most active insiders traders include Healthcare Master Fund Ltd ..., Lp22 Nw Fund, Lp22 Nw Fund ... y Dolev Rafaeli. On average, STRATA Skin Sciences Inc executives and independent directors trade stock every 127 days with the average trade being worth of $392,199. The most recent stock trade was executed by Uri Geiger on 15 July 2024, trading 230,573 units of SSKN stock currently worth $723,999.

What does STRATA Skin Sciences Inc do?

formerly mela sciences, strata skin sciences is a new company built by unconventional thinkers. a medical technology company that brings hope and help to the dermatology patient in all of us. it’s not just a device or a technology, it’s optimism for psoriasis, determination for improving patients’ lives, and advocacy for getting it right.

Complete history of Mr. Hill stock trades at STRATA Skin Sciences Inc, PDS Biotechnology y Apyx Medical

STRATA Skin Sciences Inc executives and stock owners

STRATA Skin Sciences Inc executives and other stock owners filed with the SEC include:

• Michael R. Stewart,
  Independent Consultant
• Kathryn Swintek,
  Independent Director
• David Stone,
  Independent Director
• Samuel Navarro,
  Independent Director
• Jeffrey O'Donnell,
  Director
• James Coyne,
  Director
• Matthew Hill,
  Chief Financial Officer
• Dolev Rafaeli,
  Interim Chief Executive Officer
• Frank McCaney,
  President, Director
• LuAnn Via,
  Chairman of the Board
• Nikolai Kabelev,
  VP of R&D
• Shmuel Gov,
  Exec. VP & GM
• Dr. Darrell S. Rigel,
  Chief Medical Advisor
• Keith Simeone,
  VP of Sales
• Jay Sturm,
  Gen. Counsel & Corp. Sec.
• Christopher Lesovitz,
  Chief Financial Officer
• Robert J. Moccia,
  Pres, CEO & Director
• William D. Humphries,
  Exec. Chairman
• Healthcare Master Fund Ltd ...,
  
• Michael R Stewart,
  President & CEO
• Richard Rox Anderson,
  Director
• Christina L Allgeier,
  CFO
• David N Gill,
  
• Partners, L.P.Accelmed Part...,
  
• Douglas Strang,
  
• Samuel Rubinstein,
  
• Nachum Shamir,
  
• Christopher Lesovitz,
  Chief Financial Officer
• William D. Humphries,
  
• Uri Geiger,
  Director
• Wayne Cafran,
  
• Irit Yaniv,
  
• Patricia S Walker,
  
• Robert Joseph Moccia,
  Chief Executive Officer
• Lp22 Nw Fund, Lp22 Nw Fund ...,
  
• Shmuel Gov,
  COO